Pharma company Aptuit Laurus raises Rs200 cr from Fidelity Growth Partners
14 Feb 2012
Private equity firm Fidelity Growth Partners (India) along with existing investors have invested Rs200 crore ($40.6 million) in Hyderabad-based pharma company Aptuit Laurus Pvt Ltd.
The investment comes three months after Fidelity invested an undisclosed sum in Bangalore-based medical diagnostics company XCyton Diagnostics Pvt Ltd.
Fidelity Growth Partners, the private equity arm of Boston, Massachusetts-based Fidelity Worldwide Investment, will get a 20 per cent and two board seats for its investment at Aptuit Laurus.
Chava Satyanarayana, founder and CEO of Aptuit Laurus, also invested along with Fidelity, the private equity fund said in a statement.
Aptuit is a global pharmaceutical services company focused on delivering contract development and manufacturing services and streamlining the drug development process for biotechnology and pharmaceutical innovators.
Aptuit delivers an integrated suite of product development services to more than 800 companies worldwide and manufactures active pharmaceutical ingredients for anti-retroviral, oncological and nutraceutical products.